Spotlight
Clinical
CME
Partners
Updates from Bausch and Lomb: US launch of FDA approved treatment for uveitis, new IOL toric calculator
Chuck Hess, vice president and general manager, Bausch and Lomb, discusses XIPERE™, the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients suffering from macular edema associated with uveitis, and other new things rolled out recently from the company.
Related Videos
View All
Related Content
